DK415586D0 - Monoklonale antistoffer med tumorassocierede glycoproteiner, fremgangsmaade til fremstilling deraf samt deres anvendelse - Google Patents

Monoklonale antistoffer med tumorassocierede glycoproteiner, fremgangsmaade til fremstilling deraf samt deres anvendelse

Info

Publication number
DK415586D0
DK415586D0 DK415586A DK415586A DK415586D0 DK 415586 D0 DK415586 D0 DK 415586D0 DK 415586 A DK415586 A DK 415586A DK 415586 A DK415586 A DK 415586A DK 415586 D0 DK415586 D0 DK 415586D0
Authority
DK
Denmark
Prior art keywords
glycoproteines
tumor
procedures
production
monoclonal antibodies
Prior art date
Application number
DK415586A
Other languages
English (en)
Other versions
DK415586A (da
Inventor
Klaus Bosslet
Gerhard Lueben
Ernst-Juergen Kanzy
Hans-Harald Sedlacek
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK415586D0 publication Critical patent/DK415586D0/da
Publication of DK415586A publication Critical patent/DK415586A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK415586A 1985-09-02 1986-09-01 Monoklonale antistoffer med tumorassocierede glycoproteiner, fremgangsmaade til fremstilling deraf samt deres anvendelse DK415586A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853531301 DE3531301A1 (de) 1985-09-02 1985-09-02 Monoklonale antikoerper gegen tumorassoziierte glykoproteine, verfahren zu ihrer herstellung sowie ihre verwendung

Publications (2)

Publication Number Publication Date
DK415586D0 true DK415586D0 (da) 1986-09-01
DK415586A DK415586A (da) 1987-03-03

Family

ID=6279944

Family Applications (1)

Application Number Title Priority Date Filing Date
DK415586A DK415586A (da) 1985-09-02 1986-09-01 Monoklonale antistoffer med tumorassocierede glycoproteiner, fremgangsmaade til fremstilling deraf samt deres anvendelse

Country Status (10)

Country Link
EP (1) EP0213581A3 (da)
JP (1) JP2526217B2 (da)
AU (1) AU611381B2 (da)
DE (1) DE3531301A1 (da)
DK (1) DK415586A (da)
ES (1) ES2000615A6 (da)
GR (1) GR862238B (da)
MX (1) MX3601A (da)
PT (1) PT83285B (da)
ZA (1) ZA866614B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3629640A1 (de) * 1986-08-30 1988-03-03 Behringwerke Ag Verwendung monoklonaler antikoerper zur therapie von tumoren
DE3584280D1 (de) * 1984-10-26 1991-11-07 Wakunaga Seiyaku Kk Monoklonaler antikoerper gegen menschlichen krebs.
AU601379B2 (en) * 1985-11-07 1990-09-13 Trustees Of Columbia University In The City Of New York, The Antigen indicative of human breast cancer and assays based thereon
US4926869A (en) * 1986-01-16 1990-05-22 The General Hospital Corporation Method for the diagnosis and treatment of inflammation
GB8800078D0 (en) * 1988-01-05 1988-02-10 Ciba Geigy Ag Novel antibodies
DE3825615A1 (de) * 1988-07-28 1990-02-01 Behringwerke Ag Antigenkonstrukte von "major histocompatibility complex" klasse i antigenen mit spezifischen traegermolekuelen, ihre herstellung und verwendung
JPH0266456A (ja) * 1988-08-31 1990-03-06 Saikin Kagaku Kenkyusho:Kk 疾病動物の一次診断方法、それに使用する診断試薬及びその製造方法
DE3909799A1 (de) 1989-03-24 1990-09-27 Behringwerke Ag Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416774A1 (de) * 1984-05-07 1985-11-14 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper, verfahren zu ihrer herstellung sowie ihre verwendung
DE3329184A1 (de) * 1983-08-12 1985-02-21 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene
US4585742A (en) * 1983-12-14 1986-04-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibody with specificity to human small cell carcinoma and use thereof
DK276185D0 (da) * 1984-11-09 1985-06-19 Novo Industri As Monoklonale antistoffer,fremgangsmaade til fremstilling af disse samt deres diagnostiske anvendelse
JPS61258173A (ja) * 1985-05-10 1986-11-15 Akira Taniuchi モノクロ−ナル抗体およびその製法ならびに用途
US5185432A (en) * 1986-02-26 1993-02-09 Oncogen Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas

Also Published As

Publication number Publication date
MX3601A (es) 1993-05-01
EP0213581A2 (de) 1987-03-11
JPS6269997A (ja) 1987-03-31
ES2000615A6 (es) 1988-03-01
EP0213581A3 (de) 1988-05-25
AU6214086A (en) 1987-03-05
GR862238B (en) 1986-12-31
DE3531301A1 (de) 1987-03-05
ZA866614B (en) 1987-04-29
AU611381B2 (en) 1991-06-13
DK415586A (da) 1987-03-03
JP2526217B2 (ja) 1996-08-21
PT83285B (pt) 1989-05-12
PT83285A (pt) 1986-10-01

Similar Documents

Publication Publication Date Title
DK165249C (da) Imidazooe4,5-baaquinolin-2-thionderivater samt fremgangsmaade til fremstilling deraf
FI862980A7 (fi) Kompositioner med alkylfenol- och aminofoereningar samt dessa innehaollande tvaotaktsmotoroljor och -braenslen.
DK140382A (da) Tetrahydrophthalimider og deres anvendelse,samt fremgangsmaadetil fremstilling deraf
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
NO843293L (no) Monoklonale antistoffer, samt fremgangsmaate for fremstilling av slike
DK161327C (da) Substituerede 2-piperazinopteridiner, fremgangsmaade til fremstilling deraf samt laegemidler indeholdende forbindelserne
FI862761A7 (fi) Kloonattu antigeeni.
DK426083D0 (da) Pteriner, fremgangsmader til deres fremstilling samt deres anvendelse
DK39783A (da) Goedningsmidler med styret begyndelse af naeringsstofafgivelsen, deres anvendelse samt fremgangsmaade til fremstilling deraf
DK382785A (da) Alfa-(o-chlorphenyl)-aminomethylen-beta-formylaminopropionitril, fremgangsmaade til fremstilling af dette samt anvendelse af dette til fremstilling af 2-methyl-4-amino-5-formylaminomethyl-pyrimidin
DK557289A (da) Monoklonalt, fucosylceramiderkendende antistof, dets fremstilling og anvendelse samt hybridoma til fremstillingen
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
IL70746A0 (en) Specific cea-family antigens,antibodies specific thereto and methods for the use thereof
DK415586D0 (da) Monoklonale antistoffer med tumorassocierede glycoproteiner, fremgangsmaade til fremstilling deraf samt deres anvendelse
DK393382A (da) Aminoorganoaminosilaner, fremgangsmaade til fremstilling heraf samt deres anvendelse
DK105085D0 (da) Monoklonalt antistof samt hybridom-cellelinie, der udskiller dette
NO862920L (no) Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse.
NO168225C (no) Produkt med hylster, samt fremgangsmaate for dets fremstilling.
DK105886D0 (da) Monoklone anti-alfa-amylaseantistoffer, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse antistoffer
DE3580482D1 (de) Monoklonale antikoerper und immunisierung damit.
DK115685D0 (da) Prespap samt fremgangsmaade til fremstilling deraf
DK113591A (da) 3-oe2-chlorethylaaquinazolin-2,4-dioner samt fremgangsmaade til fremstilling deraf
SE468853B (sv) Nytt lymfokin, monoklonala antikroppar specifika foer lymfokinet och deras framstaellning samt anvaendningar
EP0229107A4 (en) PROTECTIVE HUMAN MONOCLONAL ANTIBODIES TO -i(PSEUDOMONAS AERUGINOSA) EXOTOXIN A.
EP0295305A4 (en) MONOCLONAL ANTIBODY SPECIFIC TO THE SURFACE GANGLIOSIDE OF TUMOR CELLS AND HYBRIDOMA PRODUCING THE SAME.

Legal Events

Date Code Title Description
ATS Application withdrawn